Free Trial

STAAR Surgical (STAA) 10K Form and Latest SEC Filings 2026

STAAR Surgical logo
$33.72 +1.25 (+3.85%)
As of 11:03 AM Eastern

Latest STAAR Surgical SEC Filings & Recent Activity

STAAR Surgical (NASDAQ:STAA) has submitted 528+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in STAAR Surgical's financial statements. The most recent filing was a Form 10-Q submitted on May 13, 2026.

Form 4
STAAR SURGICAL CO Reports Ownership Change on Mar. 16, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
STAAR Surgical Files Current Report on May. 13, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
STAAR Surgical Files Quarterly Report on May. 13, 2026

The 10-Q contains STAAR Surgical's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

STAAR Surgical SEC Filing History

Browse STAAR Surgical's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/13/2026 3:02 PM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2026 3:06 PM
STAAR Surgical (718937) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 3:03 PM
STAAR Surgical (718937) Filer
Form DEFA14A
05/04/2026 3:05 PM
STAAR Surgical (718937) Filer
Form ARS
04/20/2026 4:24 PM
Madison Avenue Partners, LP (1801265) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13G
04/08/2026 3:05 PM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2026 12:17 PM
STAAR Surgical (718937) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/16/2026 4:00 PM
ANDREWS DEBORAH J (1325697) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 8:29 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
03/13/2026 6:59 PM
Bradsher Neal C (1278388) Reporting
BROADWOOD CAPITAL INC (1278387) Reporting
BROADWOOD PARTNERS, L.P. (1278386) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2026 6:13 PM
Bradsher Neal C (1278388) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2026 6:05 PM
LeBuhn Richard T. (1428664) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 2:58 PM
STAAR Surgical (718937) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2026 6:43 PM
STAAR Surgical (718937) Issuer
Wang Christopher Min Fang (2110712) Reporting
Form 3
Initial statement of beneficial ownership of securities  
02/05/2026 7:06 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2026 4:28 PM
ANDREWS DEBORAH J (1325697) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2026 4:29 PM
Foust Warren (1970778) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2026 6:00 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 4:14 PM
LeBuhn Richard T. (1428664) Reporting
STAAR Surgical (718937) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/16/2026 7:27 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
01/16/2026 7:03 PM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
01/16/2026 7:30 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2026 8:22 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 4:48 PM
Jiang Wei (1867980) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 8:30 PM
Bradsher Neal C (1278388) Reporting
BROADWOOD CAPITAL INC (1278387) Reporting
BROADWOOD PARTNERS, L.P. (1278386) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 6:31 PM
Bradsher Neal C (1278388) Reporting
BROADWOOD CAPITAL INC (1278387) Reporting
BROADWOOD PARTNERS, L.P. (1278386) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 12:05 PM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
01/06/2026 3:54 PM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2026 8:01 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2025 4:06 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/19/2025 2:23 PM
STAAR Surgical (718937) Filer
Form DEFA14A
12/17/2025 6:43 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
12/17/2025 4:12 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/17/2025 10:54 AM
STAAR Surgical (718937) Filer
Form DEFA14A
12/16/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/16/2025 3:01 PM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
12/16/2025 9:17 AM
STAAR Surgical (718937) Filer
Form DEFA14A
12/12/2025 7:07 PM
SISITSKY NATHANIEL (1225738) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/11/2025 4:27 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/11/2025 4:15 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
Opportunity Forming in a U.S. Supply-Chain Weak Spot? (Ad)

America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources remains high. One company appears to have spotted this gap early and is already moving to close it. The company has received federal funding as the U.S. pushes for domestic critical minerals sourcing. The story is still developing, and the market hasn't fully priced it in yet.tc pixel

See the U.S. asset positioned to close the graphite supply gap
12/11/2025 9:02 AM
STAAR Surgical (718937) Filer
Form DEFA14A
12/11/2025 6:00 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
12/11/2025 6:02 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
12/10/2025 4:22 PM
STAAR Surgical (718937) Filer
Form DEFA14A
12/10/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/09/2025 4:15 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/09/2025 7:56 AM
ALCON INC (1167379) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/09/2025 7:30 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2025 7:32 AM
STAAR Surgical (718937) Filer
Form DEFA14A
12/08/2025 4:20 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
12/08/2025 7:13 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2025 7:16 AM
STAAR Surgical (718937) Filer
Form DEFA14A
12/02/2025 4:21 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/21/2025 8:55 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
11/21/2025 8:55 PM
Bradsher Neal C (1278388) Reporting
BROADWOOD CAPITAL INC (1278387) Reporting
BROADWOOD PARTNERS, L.P. (1278386) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/17/2025 3:05 PM
STAAR Surgical (718937) Filer
Form DEFA14A
11/14/2025 5:24 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13G/A
11/14/2025 5:00 PM
Jiang Wei (1867980) Reporting
STAAR Surgical (718937) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/07/2025 12:11 PM
STAAR Surgical (718937) Filer
Form DEFA14A
11/07/2025 11:39 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/04/2025 5:04 AM
ALCON INC (1167379) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/03/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
11/03/2025 5:20 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
11/03/2025 5:25 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
10/30/2025 3:12 PM
STAAR Surgical (718937) Filer
Form DEFA14A
10/28/2025 6:00 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/27/2025 9:52 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2025 9:56 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/27/2025 5:15 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
10/27/2025 5:01 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
10/24/2025 7:09 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
10/24/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/23/2025 3:21 PM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2025 3:23 PM
STAAR Surgical (718937) Filer
Form DEFA14A
10/22/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/22/2025 5:08 AM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form SCHEDULE 13D/A
10/21/2025 5:12 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
10/21/2025 5:04 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
10/20/2025 6:49 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/20/2025 6:45 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/16/2025 4:01 PM
STAAR Surgical (718937) Filer
Form DEFA14A
10/15/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/14/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/14/2025 6:53 AM
STAAR Surgical (718937) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/09/2025 3:37 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
10/08/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/08/2025 10:48 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/07/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/07/2025 5:23 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form PX14A6G
10/07/2025 5:18 AM
STAAR Surgical (718937) Subject
Yunqi Capital Ltd (1912273) Filed by
Form SCHEDULE 13D/A
10/06/2025 4:00 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
10/06/2025 6:37 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/06/2025 6:34 AM
STAAR Surgical (718937) Filer
Form DEFA14A
10/02/2025 4:15 PM
BROADWOOD PARTNERS, L.P. (1278386) Filed by
STAAR Surgical (718937) Subject
Form DFAN14A
(Data available from 1/1/2016 forward)

STAAR Surgical SEC Filings - Frequently Asked Questions

STAAR Surgical (STAA) has submitted 528+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

STAAR Surgical's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on STAAR Surgical's financial statements page.

The most recent filing was a Form 10-Q submitted on May 13, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:STAA) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners